Feldman M, Walsh J H, Richardson C T
Dig Dis Sci. 1980 Dec;25(12):921-3. doi: 10.1007/BF01308042.
It is unknown whether the gastrin response to secretin (secretin test) can distinguish hypergastrinemia due to vagotomy from hypergastrinemia due to Zollinger-Ellison syndrome (ZES). Therefore, we measured serum gastrin concentrations basally and in response to intravenous secretin in 13 vagotomized duodenal ulcer patients without preoperative evidence evidence of ZES and in 5 vagotomized patients with ZES. Following secretin, serum gastrin concentrations increased 40 pg/ml or less [mean (+/- SE) rise 23 +/- 3 pg/ml] in the vagotomized patients without ZES. On the other hand, in the patients with ZES serum gastrin increments after secretin ranged from 105 to 1224 pg/ml. Thus, a large (> 100 pg/ml) rise in serum gastrin concentrations following secretin in a vagotomized patient should suggest Zollinger-Ellison syndrome and not be attributed to vagotomy per se.
胃泌素对促胰液素的反应(促胰液素试验)能否区分因迷走神经切断术引起的高胃泌素血症和因佐林格-埃利森综合征(ZES)引起的高胃泌素血症尚不清楚。因此,我们对13例无术前ZES证据的迷走神经切断术十二指肠溃疡患者和5例迷走神经切断术合并ZES患者,分别在基础状态下及静脉注射促胰液素后测定血清胃泌素浓度。注射促胰液素后,无ZES的迷走神经切断术患者血清胃泌素浓度升高40 pg/ml或更低[平均(±标准误)升高23±3 pg/ml]。另一方面,ZES患者注射促胰液素后血清胃泌素升高幅度在105至1224 pg/ml之间。因此,迷走神经切断术患者注射促胰液素后血清胃泌素浓度大幅升高(>100 pg/ml)应提示佐林格-埃利森综合征,而不应归因于迷走神经切断术本身。